Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1949 1
1950 2
1958 2
1960 3
1964 2
1965 1
1966 2
1967 1
1968 2
1970 2
1974 1
1975 1
1978 3
1979 1
1980 2
1985 2
1986 4
1987 1
1988 2
1989 1
1990 4
1991 3
1992 8
1993 17
1994 11
1995 4
1996 7
1997 11
1998 12
1999 14
2000 17
2001 18
2002 13
2003 13
2004 17
2005 26
2006 26
2007 29
2008 37
2009 36
2010 56
2011 76
2012 71
2013 95
2014 107
2015 110
2016 115
2017 124
2018 140
2019 139
2020 156
2021 167
2022 166
2023 182
2024 152
2025 156
2026 51

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,194 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: de melo ac. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Frailty syndrome and risks for falling in the elderly community.
Taguchi CK, Menezes PL, Melo ACS, Santana LS, Conceição WRS, Souza GF, Araújo BCL, Silva ARD. Taguchi CK, et al. Among authors: melo acs. Codas. 2022 Aug 8;34(6):e20210025. doi: 10.1590/2317-1782/20212021025pt. eCollection 2022. Codas. 2022. PMID: 35946721 Free PMC article.
Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome.
Guimarães GR, Maklouf GR, Teixeira CE, de Oliveira Santos L, Tessarollo NG, de Toledo NE, Serain AF, de Lanna CA, Pretti MA, da Cruz JGV, Falchetti M, Dimas MM, Filgueiras IS, Cabral-Marques O, Ramos RN, de Macedo FC, Rodrigues FR, Bastos NC, da Silva JL, Lummertz da Rocha E, Chaves CBP, de Melo AC, Moraes-Vieira PMM, Mori MA, Boroni M. Guimarães GR, et al. Among authors: de melo ac. Nat Commun. 2024 Jul 7;15(1):5694. doi: 10.1038/s41467-024-49916-4. Nat Commun. 2024. PMID: 38972873 Free PMC article.
Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.
Oaknin A, Monk BJ, de Melo AC, Kim HS, Kim YM, Lisyanskaya AS, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin E, Takahashi S, Ramone D, Maćkowiak-Matejczyk B, Polastro L, Alia EMG, Colombo N, Makarova Y, Goh JC, Hasegawa K, Mora P, Pikiel J, Srivastav R, Rischin D, Rubio MJ, Perez J, Yoo SY, Gao B, Jamil S, Seebach F, Lowy I, Mathias M, Fury MG, Tewari KS. Oaknin A, et al. Among authors: de melo ac. Eur J Cancer. 2025 Feb 5;216:115146. doi: 10.1016/j.ejca.2024.115146. Epub 2025 Jan 10. Eur J Cancer. 2025. PMID: 39798514 Clinical Trial.
Horticultural Crops under Stresses.
de Melo AS, Gheyi HR. de Melo AS, et al. Plants (Basel). 2023 Sep 26;12(19):3400. doi: 10.3390/plants12193400. Plants (Basel). 2023. PMID: 37836140 Free PMC article.
Human outbreaks of a novel reassortant Oropouche virus in the Brazilian Amazon region.
Naveca FG, Almeida TAP, Souza V, Nascimento V, Silva D, Nascimento F, Mejía M, Oliveira YS, Rocha L, Xavier N, Lopes J, Maito R, Meneses C, Amorim T, Fé L, Camelo FS, Silva SCA, Melo AX, Fernandes LG, Oliveira MAA, Arcanjo AR, Araújo G, André Júnior W, Carvalho RLC, Rodrigues R, Albuquerque S, Mattos C, Silva C, Linhares A, Rodrigues T, Mariscal F, Morais MA, Presibella MM, Marques NFQ, Paiva A, Ribeiro K, Vieira D, Queiroz JADS, Passos-Silva AM, Abdalla L, Santos JH, Figueiredo RMP, Cruz ACR, Casseb LN, Chiang JO, Frutuoso LV, Rossi A, Freitas L, Campos TL, Wallau GL, Moreira E, Lins Neto RD, Alexander LW, Sun Y, Filippis AMB, Gräf T, Arantes I, Bento AI, Delatorre E, Bello G. Naveca FG, et al. Among authors: melo ax. Nat Med. 2024 Dec;30(12):3509-3521. doi: 10.1038/s41591-024-03300-3. Epub 2024 Sep 18. Nat Med. 2024. PMID: 39293488
Chronic urticaria treatment challenges in children.
Ensina LF, Brandão LS, Melo ACDB, Antila M, Ben-Shoshan M, Solé D. Ensina LF, et al. Among authors: melo acdb. Rev Paul Pediatr. 2024 Dec 20;43:e2024107. doi: 10.1590/1984-0462/2025/43/2024107. eCollection 2024. Rev Paul Pediatr. 2024. PMID: 39775610 Free PMC article. Review.
Reweighting simulated events using machine-learning techniques in the CMS experiment.
Hayrapetyan A, Tumasyan A, Adam W, Andrejkovic JW, Benato L, Bergauer T, Chatterjee S, Damanakis K, Dragicevic M, Hussain PS, Jeitler M, Krammer N, Li A, Liko D, Mikulec I, Schieck J, Schöfbeck R, Schwarz D, Sonawane M, Waltenberger W, Wulz CE, Janssen T, Van Laer T, Van Mechelen P, Breugelmans N, D'Hondt J, Dansana S, De Moor A, Delcourt M, Heyen F, Lowette S, Makarenko I, Müller D, Tavernier S, Tytgat M, Van Onsem GP, Van Putte S, Vannerom D, Bilin B, Clerbaux B, Das AK, De Bruyn I, De Lentdecker G, Evard H, Favart L, Gianneios P, Jaramillo J, Khalilzadeh A, Khan FA, Lee K, Malara A, Paredes S, Shahzad MA, Thomas L, Vanden Bemden M, Vander Velde C, Vanlaer P, De Coen M, Dobur D, Gokbulut G, Hong Y, Knolle J, Lambrecht L, Marckx D, Mota Amarilo K, Skovpen K, Van Den Bossche N, van der Linden J, Wezenbeek L, Benecke A, Bethani A, Bruno G, Caputo C, De Favereau De Jeneret J, Delaere C, Donertas IS, Giammanco A, Guzel AO, Jain S, Lemaitre V, Lidrych J, Mastrapasqua P, Tran TT, Turkcapar S, Alves GA, Coelho E, Correia Silva G, Hensel C, Menezes De Oliveira T, Mora Herrera C, Rebello Teles P, Soeiro M, Tonelli Manganote EJ, Vilela Pereira A, Aldá Júnior WL, Barroso Ferreira Filho M, B… See abstract for full author list ➔ Hayrapetyan A, et al. Among authors: melo a. Eur Phys J C Part Fields. 2025;85(5):495. doi: 10.1140/epjc/s10052-025-14097-x. Epub 2025 May 6. Eur Phys J C Part Fields. 2025. PMID: 40342237 Free PMC article.
Adjuvant nivolumab and relatlimab in stage III/IV melanoma: the randomized phase 3 RELATIVITY-098 trial.
Long GV, Garnett-Benson C, Dolfi S, Ascierto PA, Guo J, Tarhini AA, Chandra S, Muñoz-Couselo E, Del Vecchio M, de Melo AC, Callahan M, Gogas H, Dummer R, Schadendorf D, Koelblinger P, Quereux G, Thomas I, Yu JX, Fisher A, Wang B, Djidel P, Chouzy A, Semaan M, Chen B, Cheong AMY, Tawbi HA. Long GV, et al. Among authors: de melo ac. Nat Med. 2025 Dec;31(12):4301-4309. doi: 10.1038/s41591-025-04032-8. Epub 2025 Oct 18. Nat Med. 2025. PMID: 41109920 Free PMC article. Clinical Trial.
2,194 results